About Careers MedBlog Contact us

Cholesterol-Busting Drugs Can Reduce Death Rates by 40% Among Cancer Patients

by Vishnuprasad on June 3, 2015 at 5:44 PM
Font : A-A+

Cholesterol-Busting Drugs Can Reduce Death Rates by 40% Among Cancer Patients

Taking statins - any of a group of drugs, which act to reduce levels of cholesterol in the blood - can increase the chance of patients surviving cancer by up to 55%, suggests a new study.

Ange Wang, an author of the study, said that a daily dose of the cholesterol-busting drug could be a major weapon in the war on the disease. The research found that statins reduced the death rates at least by 40% among people with most common cancers such as breast, prostate, bowel and ovarian.


When all cancers were taken into consideration, those patients on the drug were 20% less likely to die.

The biggest difference was the 55% reduction for bone cancer sufferers. Professor Noel Clarke, of The Christie cancer center in Manchester, said the study added weight to the case for taking statins.

He added: "The balance of evidence says that statins have an anti-cancer effect."

Wang and her research team at the Stanford University School of Medicine studied 150,000 women.

An investigation by the Rutgers Cancer Institute of New Jersey analysed death rates of 20,000 men with prostate cancer.

The findings were presented in Chicago at the annual meeting of the American Society of Clinical Oncology.

However, the US studies did not show the drug prevents people getting the disease.

Source: Medindia


Recommended Reading

Latest Cancer News

Link Between Gut Microbiome and Precancerous Colon Polyps Identified
Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.
 Analyzing Paediatric Brain Tumours Provide Data for Cancer Research
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
Cancer Drugs to be Tested in Orbit During American Private Astronaut Mission
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
 Hydrogen Sulfide Makes Cancer Cells More Sensitive to Photothermal Therapy
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Hidden Influence of Gut Microbiome on Early-Onset Colorectal Cancer
Colon cancer's hidden link revealed in microbiome study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cholesterol-Busting Drugs Can Reduce Death Rates by 40% Among Cancer Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests